Download Monoamine Oxidase (MAO) Inhibition Assay

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts
no text concepts found
Transcript
In vitro ADME & PK
Monoamine Oxidase
(MAO) Inhibition
Background Information
• Monoamine oxidases (MAO) are
membrane-associated enzymes located
specifically to the outer mitochondrial
membrane. They are the major enzymes
participating in the catabolism of
monoamine neurotransmitters and related
exogenous amines.
‘In human brain the predominant
form is MAO-B, expressed at
highest levels in astrocytes and
serotonergic neurons, while
MAO-A is expressed at highest
levels in catecholaminergic
neurons.’
Hotamisligil GS and Breakefield
XO (1991) Am J Hum Genet 49(2);
383–392
1
• Two isoforms of MAO exist, MAO-A and
MAO-B, which differ in their substrate
specificity, inhibitor selectivity and tissue
distribution.
• Selective MAO-A inhibitors are useful in the
therapy of depression and anxiety whereas
MAO-B inhibitors are often used in the
treatment of Parkinson’s and Alzheimer’s
diseases.
• Cyprotex’s MAO inhibition assay identifies
if your compound is an inhibitor for either
MAO-A or MAO-B.
Protocol
Substrate
Kynuramine
Metabolite
4-hydroxyquinolinol
Test Article Concentrations
0, 0.4, 1, 4, 10, 40 and 100 µM
(different concentrations available)
Enzyme Source
hMAO-A and hMAO-B expressed enzymes
(SupersomesTM)
Test Article Requirements
100 µL of a 40 mM DMSO solution (or equivalent
amount in solid)
Positive Control
Clorgyline MAO-A
Selegiline MAO-B
Analysis Method
LC-MS/MS
Data Delivery
IC50
Standard error of IC50
% Control at each concentration
To find out more contact [email protected]
Monoamine Oxidase (MAO) is a critical enzyme in the degradative deanimation of biogenic
amines throughout the body1.
Figure 1
Inhibitory specificity demonstrated for MAO-A inhibitor clorgyline using MAO-A or
MAO-B expressed enzyme and kynuramine as the substrate.
% Control
120
100
Clorgyline
MAO-A
80
Clorgyline
MAO-B
60
40
20
0
0.00001
0.0001
0.001
0.01
0.1
1
Clorgyline concentration (µM)
0.5
Figure 2
Assay 2
Assay 3
0.4
IC50 (µM)
Inter-assay reproducibility of MAO-B inhibition using
specific MAO-B inhibitor selegiline and non-specific inhibitor
tranylcypromine. Each inhibitor was investigated on three
separate occasions using hMAO-B expressed enzyme and
kynuramine as substrate. The error bars represent the stadard
error of the IC50 determination.
Assay 1
0.3
0.2
0.1
0
References
1
Hotamisligil GS and Breakefield XO (1991) Human monoamine oxidase A gene determines levels
of enzyme activity. Am J Hum Genet 49(2); 383-392
Selegiline
Tranylcypromine